Please ensure Javascript is enabled for purposes of website accessibility

Tag Archives: Northwest Biotherapeutics Inc.

NW Bio receives added funding

Northwest Biotherapeutics, of Bethesda, a biotechnology company, has raised $35 million in financing, the company announced. The funds come from a $25 million equity investment by British-based C.F. Woodford Equity Income Fund and a $10 million mortgage on the company’s ...

Read More »

Northwest Bio’s loss doubles in a year

Northwest Biotherapeutics Inc., of Bethesda, a development-stage biotechnology company focused on developing therapies to improve the body’s immune response to cancer, reported a net loss of $67.3 million, or 5.72 per share, in the 12 months ended Dec. 31, 2012, compared to a loss of $32.8 million, or $5.58 per share, for the same period in 2011.

Read More »